This inventor holds 2 USPTO granted patents. Top assignee: Novartis Ag. Active years: 2002-2005.
Company Filing History:
Years Active: 2002-2005
Title: Iain Fraser James: Innovator in Pain Detection
Introduction
Iain Fraser James is a notable inventor based in London, GB. He has made significant contributions to the field of pain detection through his innovative work. With a total of 2 patents, his research focuses on the vanilloid receptor, which plays a crucial role in the detection of noxious stimuli in mammals.
Latest Patents
James's latest patents include the isolated nucleic acid encoding the human vanilloid receptor. This receptor, along with its preparation and the cells expressing it, is essential for testing compounds that may decrease pain in humans. The receptor's involvement in detecting harmful stimuli highlights its importance in medical research and potential therapeutic applications.
Career Highlights
Iain Fraser James is currently associated with Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to further his research and contribute to advancements in pain management. His expertise in the field has positioned him as a valuable asset to the company.
Collaborations
James collaborates with various professionals in his field, including his coworker, Peter McIntyre. Their combined efforts aim to enhance the understanding and treatment of pain through innovative research.
Conclusion
Iain Fraser James is a prominent inventor whose work on the vanilloid receptor has the potential to revolutionize pain detection and management. His contributions to the field are significant and continue to impact medical research positively.